BioWorld. Link to homepage.

Clarivate
  • BioWorld
  • BioWorld Science
  • BioWorld Asia
  • Data Snapshots
    • Biopharma
    • Medical technology
    • Infographics: Dynamic digital data analysis
    • Index insights
    • NME Digest
  • Special reports
    • Infographics: Dynamic digital data analysis
    • Trump administration impacts
    • Med-tech outlook 2026
    • Under threat: mRNA vaccine research
    • BioWorld at 35
    • Biopharma M&A scorecard
    • Bioworld 2025 review
    • BioWorld MedTech 2025 review
    • BioWorld Science 2025 review
    • Women's health
    • China's GLP-1 landscape
    • PFA re-energizes afib market
    • China CAR T
    • Alzheimer's disease
    • Coronavirus
    • More reports can be found here

BioWorld. Link to homepage.

  • Sign In
  • Sign Out
  • My Account
Subscribe
BioWorld - Friday, March 13, 2026
Home » Newsletters » BioWorld Science

BioWorld Science

June 11, 2003

View Archived Issues

The EP4 agonist Ono-4819 accelerates bone healing in rats

Read More

CGP-41251 demonstrates novel immunosuppressive activity

Read More

Inhibition of p38 MAPK with FR-167653 prevents the onset and progression of arthritis in rats

Read More

D-003 prevents bone loss and reduces bone resorption in ovariectomized rats

Read More

CC-5013 inhibits adhesion molecules and prevents metastasis in an animal model

Read More

Good safety profile for peginterferon alfa-2a in malignant melanoma

Read More

MEDI-522 well tolerated in patients with refractory colorectal cancer

Read More

Pfizer presents promising preclinical data for CP-690550

Read More

Halofuginone efficacy and pharmacokinetic data presented at ASCO

Read More

Evidence of antitumor effects found for endostatin in neuroendocrine tumors

Read More

Once daily NM-3 is well tolerated and has antitumor activity in advanced solid tumors

Read More

ABT-510 is well tolerated and induces antitumor response in cancer patients

Read More

Evaluation of the antiangiogenic effects of chemotherapy using dynamic MRI

Read More

Biogen/Icos LFA-1 collaboration is concluded

Read More

BioSante signs biodefense vaccine CRADA with U.S. Army

Read More

Final phase IIa results from kidney transplant study of ISA-247

Read More

ATL-1101 silences target gene in lab psoriasis studies

Read More

CHF-3381 proceeds to proof-of-concept study

Read More

Four related series of antiviral neuraminidase inhibitors reported by Biota

Read More

New alpha4 integrin antagonists and their use in IBD, asthma, arthritis, etc.

Read More

Novel glycogen phosphorylase inhibitors prepared and tested by JT researchers

Read More

AstraZeneca scientists present new P2X7 receptor antagonists in a recent patent

Read More

New cannabinoid CB2 receptor ligands in early development at Schering-Plough

Read More

New PDE5 inhibitors in Schering-Plough development pipeline

Read More

Compounds able to inhibit HDM2 or MDM2 binding to p53 and their use as antitumor agents

Read More

Inverse agonism of the CB1 receptor increases energy expenditure

Read More

Serotonin 5-HT6 receptor antagonism attenuates food intake and body weight

Read More

HMR-1426: a potent orally active anoretic

Read More

Popular Stories

  • Today's news in brief

    BioWorld
    BioWorld briefs for March 12, 2026.
  • Microscopic image of clear cell carcinoma, the most common type of renal cell carcinoma.

    Cas and effect: Merck’s phase III ripples HIF-2α space

    BioWorld
    Oddsmakers wasted no time figuring the market chances after Merck & Co. Inc. rolled out data from the phase III Litespark-011 study testing its oral...
  • Tanycytes in green capturing tau protein in red.

    Brain’s hidden tau-clearing pathway uncovered

    BioWorld Science
    Researchers at INSERM and collaborators have identified hypothalamic tanycytes as mediators of tau clearance and shown that their structural and genetic...
  • News in brief

    BioWorld Asia
    BioWorld Asia briefs for March 10, 2026
  • MSD synthesizes α-synuclein PET agents

    BioWorld Science
    Merck Sharp & Dohme LLC (MSD) has prepared and tested new positron emission tomography (PET) agents for binding and imaging α-synuclein (SNCA) for the diagnosis...
  • BioWorld
    • Today's news
    • Analysis and data insight
    • Clinical
    • Data Snapshots
    • Deals and M&A
    • Financings
    • Medical technology
    • Newco news
    • Opinion
    • Regulatory
  • BioWorld Science
    • Today's news
    • Biomarkers
    • Cancer
    • Conferences
    • Endocrine/metabolic
    • Immune
    • Infection
    • Neurology/psychiatric
    • NME Digest
    • Patents
  • BioWorld Asia
    • Today's news
    • Analysis and data insight
    • Australia
    • China
    • Clinical
    • Deals and M&A
    • Financings
    • Newco news
    • Regulatory
    • Science
  • More
    • About
    • Advertise with BioWorld
    • Archives
    • Article reprints and permissions
    • Contact us
    • Cookie policy
    • Copyright notice
    • Data methodology
    • Infographics: Dynamic digital data analysis
    • Index insights
    • Podcasts
    • Privacy policy
    • Share your news with BioWorld
    • Staff
    • Terms of use
    • Topic alerts
Follow Us

Copyright ©2026. All Rights Reserved. Design, CMS, Hosting & Web Development :: ePublishing